Skip to content

EPAD Monitoring of Patients Undergoing Robotic Assisted Laparoscopic Genitourinary Surgery

EPAD Monitoring of Patients Undergoing Robotic Assisted Laparoscopic Genitourinary Surgery

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03319407
Enrollment
21
Registered
2017-10-24
Start date
2017-10-05
Completion date
2018-12-30
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Brief summary

Participants to be enrolled in this study will have been scheduled to have laparoscopic genitourinary surgery and EPAD monitoring as part of their clinical care intraoperatively. Patients scheduled for genitourinary surgery are often at risk for developing nerve injuries due to intraoperative positioning. Somatosensory evoked potential devices (SSEP) are commonly used to detect pending injury to peripheral nerves. The purpose of the present study is to use SSEP monitoring to determine the incidence and potential causes of significant changes in SSEP waveforms and correlate these changes with neurologic status of the brachial plexus after robotic surgery.

Interventions

DEVICEEPAD monitoring system

EPAD system will be used as part of routine care

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo robotic assisted laparoscopic genitourinary surgery * Patients who are scheduled to have EPAD monitoring as part of their clinical care intraoperatively

Exclusion criteria

• Patients with previous history of polyneuropathy, carpal tunnel, ulnar neuropathy, or similar neurological deficiencies

Design outcomes

Primary

MeasureTime frameDescription
Somatosensory Evoked Potential Monitoringin the first 24 hours of postoperative periodRecording of somatosensory evoked potential in patients undergoing genitourinary surgery

Countries

United States

Participant flow

Participants by arm

ArmCount
Observation
All participants will be monitored with EPAD system EPAD monitoring system: EPAD system will be used as part of routine care
21
Total21

Baseline characteristics

CharacteristicObservation
Age, Continuous63 years
STANDARD_DEVIATION 11
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
5 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
16 Participants
Region of Enrollment
United States
21 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 21
other
Total, other adverse events
0 / 21
serious
Total, serious adverse events
0 / 21

Outcome results

Primary

Somatosensory Evoked Potential Monitoring

Recording of somatosensory evoked potential in patients undergoing genitourinary surgery

Time frame: in the first 24 hours of postoperative period

Population: Study terminated prematurely. Data was not collected.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026